Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation
1 other identifier
observational
70
1 country
1
Brief Summary
This study aims to assess the residual tumoral activity versus the well ablation of اepatocellular carcinoma (HCC) post radiofrequency ablation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
April 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedFirst Posted
Study publicly available on registry
May 7, 2025
CompletedMay 20, 2025
May 1, 2025
4 months
April 28, 2025
May 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity of fluoro-2- deoxy-D-glucose (FDG) Positron emission tomography (PET) /computed tomography (CT) to predict hepatocellular carcinoma (HCC)
Sensitivity of fluoro-2- deoxy-D-glucose (FDG) Positron emission tomography (PET) /computed tomography (CT) to predict hepatocellular carcinoma (HCC) will be measured.
From 1 month to 3 months post radiofrequency ablation
Secondary Outcomes (3)
The value of fluoro-2- deoxy-D-glucose (FDG) Positron emission tomography (PET) /computed tomography (CT)
From 1 month to 3 months post radiofrequency ablation
Serum Alpha-Fetoprotein (AFP) level
From 1 month to 3 months post radiofrequency ablation
Mean diameter of ablated area and the mean of Liver standardized uptake value (SUvmax) .
From 1 month to 3 months post radiofrequency ablation
Study Arms (1)
PET/CT
Hybrid positron emission tomography (PET) and computed tomography (CT) images will be performed using Philips hybrid system equipped with a 16 MDCT scanner. The whole-body PET images from the skull vault down to the knee will be performed using several bed positions acquisition, each bed is approximately 15cm axial filed with 4mm special resolution. The time of acquisition of the emission scan is about 2 min for each bed, with a total time range between 12 and 17 min.
Interventions
Hybrid positron emission tomography (PET) and computed tomography (CT) images will be performed using Philips hybrid system equipped with a 16 MDCT scanner. The whole-body PET images from the skull vault down to the knee will be performed using several bed positions acquisition, each bed is approximately 15cm axial filed with 4mm special resolution. The time of acquisition of the emission scan is about 2 min for each bed, with a total time range between 12 and 17 min.
Eligibility Criteria
This prospective cohort study will be carried out on 70 patients with hepatocellular malignancy at Tanta University Hospitals for a period from April 2025 to September 2025 after approval from institutional ethical committee.
You may qualify if:
- Age from 40 to 75 years.
- Both sexes.
- Patients with hepatocellular carcinoma (HCC) and underwent radiofrequency ablation (RFA) .
You may not qualify if:
- Patients with past history of contrast allergy.
- Patients with blood glucose level \>200 mg/dl at the time of the study.
- High serum creatinine\> 2 mg / dl.
- Small lesions \< 10 mm.
- Well differentiated hepatocellular carcinoma (HCC) lesions by pathology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, El-Gharbia, 31527, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Diagnostic Radiology and Medical Imaging, Faculty of Medicine, Tanta University, Tanta, Egypt.
Study Record Dates
First Submitted
April 28, 2025
First Posted
May 7, 2025
Study Start
December 30, 2024
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
May 20, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.